Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)
Clinical trial NCT04267120 · TERMINATED
Trial details
- NCT number
- NCT04267120
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2024-05-09
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.